Exact Mass: 341.1524

Exact Mass Matches: 341.1524

Found 68 metabolites which its exact mass value is equals to given mass value 341.1524, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mycotoxin T 2

N-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidate

C16H23NO7 (341.1474)


Isolated from seed pods of Moringa oleifera (horseradish tree). Mycotoxin T 2 is found in fats and oils, herbs and spices, and green vegetables. Mycotoxin T 2 is found in fats and oils. Mycotoxin T 2 is a mycotoxin T 2 is isolated from seed pods of Moringa oleifera (horseradish tree)

   

Histidyltryptophan

(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C17H19N5O3 (341.1488)


Histidyltryptophan is a dipeptide composed of histidine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tryptophyl-Histidine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-(1H-imidazol-5-yl)propanoate

C17H19N5O3 (341.1488)


Tryptophyl-Histidine is a dipeptide composed of tryptophan and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Histidinyl-Tryptophan

2-{[2-amino-1-hydroxy-3-(3H-imidazol-4-yl)propylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C17H19N5O3 (341.1488)


   

NCGC00385937-01

NCGC00385937-01

C16H23NO7 (341.1474)


   

Monocrotaline N-Oxide

Monocrotaline N-Oxide

C16H23NO7 (341.1474)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 173 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 163 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 153 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 143 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 133 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 123 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 113 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 103 INTERNAL_ID 103; CONFIDENCE Reference Standard (Level 1)

   

N-acetyltyramine 1-O-beta-glucoside

N-acetyltyramine 1-O-beta-glucoside

C16H23NO7 (341.1474)


   

6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

C16H23NO7 (341.1474)


   
   
   

2LCP0RBK6G

2H-(1,6)DIOXACYCLOUNDECINO(2,3,4-GH)PYRROLIZINE-2,6(3H)-DIONE, 4,5,8,10,12,13,13A,13B-OCTAHYDRO-4,5-DIHYDROXY-3,4,5-TRIMETHYL-, 11-OXIDE, (3R,4S,5S,13AR,13BR)-

C16H23NO7 (341.1474)


Monocrotaline N-Oxide, a monocrotaline metabolite, leads to DNA adduct formation in vivo[1].

   

Dapoxetine Hydrochloride

Dapoxetine hydrochloride (Priligy)

C21H24ClNO (341.1546)


C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide

NCGC00385937-01_C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide

C16H23NO7 (341.1474)


   

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

C16H23NO7 (341.1474)


   
   
   
   
   
   

PC(0:0/5:0)

3,5,8-Trioxa-4-phosphatridecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

C13H28NO7P (341.1603)


   

PC(0:0/5:0)[U]

3,5,8-Trioxa-4-phosphatridecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C13H28NO7P (341.1603)


   

His-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-5-yl)propanoic acid

C17H19N5O3 (341.1488)


A dipeptide formed from L-histidine and L-tryptophan residues.

   

TRP-His

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C17H19N5O3 (341.1488)


   

Mycotoxin T 2

ethyl N-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)carbamate

C16H23NO7 (341.1474)


   

LPC 5:0

2-valeryl-sn-glycero-3-phosphocholine

C13H28NO7P (341.1603)


   

N-Acetylmetoclopramide

N-Acetylmetoclopramide

C16H24ClN3O3 (341.1506)


   

METHYL 2-FLUORO-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE

METHYL 2-FLUORO-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE

C20H20FNO3 (341.1427)


   

Z-D-Asp(OtBu)-OH.H2O

Z-D-Asp(OtBu)-OH.H2O

C16H23NO7 (341.1474)


   

2-Ethylhexanoate manganese

2-Ethylhexanoate manganese

C16H30MnO4 (341.1524)


   

Leminoprazole

2-(1H-benzimidazol-2-ylsulfinylmethyl)-N-methyl-N-(2-methylpropyl)aniline

C19H23N3OS (341.1562)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor

   

N-(2-chloro-6-cyanopyridin-3-yl)pivalamide

N-(2-chloro-6-cyanopyridin-3-yl)pivalamide

C16H24ClN3O3 (341.1506)


   

4H-Benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol,10-methoxy-4-(1-methyl-4-piperidinyl)-

4H-Benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol,10-methoxy-4-(1-methyl-4-piperidinyl)-

C20H23NO2S (341.1449)


   

2-(4-CBZ-PIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID

2-(4-CBZ-PIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID

C17H20BN3O4 (341.1547)


   

Clobenztropine

Clobenztropine

C21H24ClNO (341.1546)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

AMIPRILOSEHYDROCHLORIDE

AMIPRILOSEHYDROCHLORIDE

C14H28ClNO6 (341.1605)


   
   
   

manganese(II) isooctanoate

manganese(II) isooctanoate

C16H30MnO4 (341.1524)


   

N-(4-Fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-(4-Fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C19H21BFNO3 (341.1598)


   

Manganese bis(2-ethylhexanoate)

Manganese bis(2-ethylhexanoate)

C16H30MnO4 (341.1524)


   

Phendimetrazine tartrate

Phendimetrazine tartrate

C16H23NO7 (341.1474)


D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

N-(4-anilinophenyl)-3-(hydroxymethyl)-1-piperidinecarbothioamide

N-(4-anilinophenyl)-3-(hydroxymethyl)-1-piperidinecarbothioamide

C19H23N3OS (341.1562)


   

(1R,5S)-3beta-(4-Chlorobenzhydryloxy)tropane

(1R,5S)-3beta-(4-Chlorobenzhydryloxy)tropane

C21H24ClNO (341.1546)


   
   

Heptylpenicillin

Heptylpenicillin

C16H25N2O4S- (341.1535)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

6-[4-(1-phenylethylamino)-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

6-[4-(1-phenylethylamino)-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

C22H19N3O (341.1528)


   

2-[4-(4-nitrophenyl)-1-piperazinyl]-N-(2-pyridinyl)acetamide

2-[4-(4-nitrophenyl)-1-piperazinyl]-N-(2-pyridinyl)acetamide

C17H19N5O3 (341.1488)


   

L-glutamyl-L-prolyl-L-proline

L-glutamyl-L-prolyl-L-proline

C15H23N3O6 (341.1587)


   

4-benzyl-N-(3-methoxyphenyl)piperazine-1-carbothioamide

4-benzyl-N-(3-methoxyphenyl)piperazine-1-carbothioamide

C19H23N3OS (341.1562)


   

3-[3-(4-Tert-butylphenoxy)propyl]-1,3-benzothiazol-2-one

3-[3-(4-Tert-butylphenoxy)propyl]-1,3-benzothiazol-2-one

C20H23NO2S (341.1449)


   
   

(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C19H20FN3O2 (341.1539)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octanoate

C13H28NO7P (341.1603)


   

(2-Hydroxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hydroxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C13H28NO7P (341.1603)


   

2-valeryl-sn-glycero-3-phosphocholine

2-valeryl-sn-glycero-3-phosphocholine

C13H28NO7P (341.1603)


   
   

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid

C16H23NO7 (341.1474)


   

6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

NA

C16H23NO7 (341.1474)


{"Ingredient_id": "HBIN012063","Ingredient_name": "6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline","Alias": "NA","Ingredient_formula": "C16H23NO7","Ingredient_Smile": "CC1C2=CC(=C(C=C2CCN1C3(C(C(C(CO3)O)O)O)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6032","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

n-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C16H23NO7 (341.1474)


   

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid

C16H23NO7 (341.1474)


   

n-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

n-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C16H23NO7 (341.1474)


   

(2r)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-3-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propanoic acid

(2r)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-3-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propanoic acid

C15H23N3O6 (341.1587)